Representative Matters
REFERENZMANDATE
代表事项
Public Company Transactions
- Ocera Therapeutics, in its acquisition by Mallickrodt for up to $117 million in upfront cash and contingent (CVR) consideration
- Allena Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, in its $75 million initial public offering on the NASDAQ Stock Market
- Chiasma, a late-stage biopharmaceutical company, in its $102 million initial public offering on the NASDAQ Stock Market
- J.P. Morgan and Barclays Capital in the $184 million initial public offering of Intrexon Corporation, a synthetic biology company, on the NYSE
- J.P. Morgan and BofA Merrill Lynch in the $116 million follow-on offering of Intrexon Corporation
- JMP Securities in the $230 million follow-on offering of Intrexon Corporation
- Cantor Fitzgerald in a $200 million “at the market” offering facility for Intrexon Corporation
- Foundation Medicine, a cancer diagnostics company, in (i) its $120 million initial public offering on the NASDAQ Stock Market and (ii) its collaboration agreement and equity transaction with Roche, total value in excess of $1 billion
- Ocera Therapeutics, a biotechnology company, in its $28 million PIPE financing, $25 million public offering and $25 million “at the market” offering facility
- Vivo Capital in its participation in a $12.5 million unit offering of BioPharmX
- Vivo Capital, as lead investor, in a $35 million financing of Strongbridge Pharma
M & A
- Glossier in its acquisition of Dynamo E-Media
- Represented Thar Pharmaceuticals, a biopharmaceutical company, in its acquisition by an affiliate of The Grünenthal Group
- Songza, a streaming music company, in its sale to Google
- M5 Networks, a cloud communications company, in its $146 million acquisition by ShorTel
- XGraph, a social targeting company, in its acquisition by Add This (formerly Clearspring)
- Fidelis Security Systems, a cybersecurity company, in its acquisition by General Dynamics
- Nomi Technologies, a retail technology company, in its acquisition by Brickstream Corporation
- Represented Tagman, the pioneer tag management and attribution company, in its acquisition by Ensighten
Private Financings
- Glossier in its $52 million financing led by Institutional Venture Partners and Index Ventures
- Codiak BioSciences in its $76.5 million financing with participation by ARCH Venture Partners, Flagship Pioneering, Fidelity Management and Research Company, the Alaska Permanent Fund, and Alexandria Venture Investments, Qatar Investment Authority, Boxer Capital of the Tavistock Group, Sirona Capital, EcoR1 Capital and Casdin Capital
- Hermed Capital in its investments in Prognos and Spineology
- Celtra in its $15.0 million financing by affiliates of WPP and Unilever
- Syntimmune in its $50.0 million financing led by Apple Tree Partners
- Glasswing Ventures as lead investor in an $8.3 million financing of Talla
- PatientBank in its $2.2 million financing led by General Catalyst and Khosla Ventures with participation by SV Angels, Spectrum 28 and Data Collective
- Hubble Contacts in its $16.5 million financing led by First Mark Capital, Greycroft, Two River and Wildcat Capital Management
- Glossier in its $24 million Series B financing led by Institutional Venture Partners, with participation from Index Ventures, Thrive Capital and Forerunner Ventures
- Hubble Contacts in $7.2 million seed financings backed by Wildcat Capital Management, Two River, Founders Fund and Greycroft Partners
- Aircall.io in its $8 million financing led by Baldteron Capital
- Allena Pharmaceuticals in its $53 million Series C financing led by Partner Fund Management, Fidelity and Wellington
- Codiak BioSciences in its $80 million financing led by Arch Venture Partners and Flagship Ventures
- InterWest and Orbimed, as lead investors, in a $32 million investment round of Avedro
- HYPR Brands in its $5 million financing led by Silvertech Ventures, Edgewater Equity and a number of other strategic investors.
- Precision Biologics in its $50 million financing by an affiliate of NantWorks
- Orchard Platform in its $30 million financing led by Thrive Capital, Spark Capital and Canaan Partners
- Even Financial in its $2.8 million financing led by Canaan Partners and Lerer Hippeau Ventures
- Into the Gloss (d/b/a Glossier) in its $8.4 million financing led by Thrive Capital
- Pond5 in its $61 million financing by Accel Partners and Stripes Group
- Paperless Post in its $25 million financing led by August Capital
- Megaphone TV in its $4.3 million financing led by Softbank Korea
- Nomi Technologies in its $10 million financing by Accel Partners, First Round Capital, Greycroft Partners and Forerunner
Professional Activities
Mr. Lang is a frequent lecturer at the Cardozo Tech Law Start Up Clinic, Columbia Business School, Columbia Law School, Cornell Tech and eLab NYC on venture financings and other elements of start-up law.
Professional Experience
Prior to joining Goodwin, Mr. Lang was an associate in the New York office of Heller Ehrman.